All Stories

  1. Concordance of Direct and Indirect Measures of Medication Adherence in A Treatment Trial for Cannabis Dependence

    Article • Journal of Substance Abuse Treatment, October 2015, Elsevier

    Professor Lindsay DeVane

  2. Practice What We Publish

    Article • Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy, April 2015, Wiley

    Professor Lindsay DeVane

  3. An Epidemic of Opioid Prescriptions

    Article • Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy, March 2015, Wiley

    Professor Lindsay DeVane

  4. Parents and Mentors May Be Gone but They Are Never Forgotten

    Article • Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy, January 2015, Wiley

    Professor Lindsay DeVane

  5. Basic Science and the Ebola Virus Infection Epidemic

    Article • Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy, November 2014, Wiley

    Professor Lindsay DeVane

  6. Behind the Cover atPharmacotherapy

    Article • Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy, February 2014, Wiley

    Professor Lindsay DeVane

  7. Pig Fat, Pork Bellies, and Portly Appearance

    Article • Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy, December 2013, Wiley

    Professor Lindsay DeVane

  8. Marijuana Use in America: Whither Are We Bound?

    Article • Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy, October 2013, Wiley

    Professor Lindsay DeVane

  9. What Evidence is Required for Drug Exposure to be Causally Associated with Adverse Events? The Case for Case Reports Published inPharmacotherapy

    Article • Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy, February 2013, Wiley

    Professor Lindsay DeVane

  10. Celebrating 32 Years of Pharmacotherapy

    Article • Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy, January 2013, Wiley

    Professor Lindsay DeVane

  11. Human Psychopharmacology: the first twenty-five years

    Article • Human Psychopharmacology Clinical and Experimental, January 2012, Wiley

    Professor Lindsay DeVane

  12. Exposing Fetal Drug Exposure

    Article • Clinical Pharmacology & Therapeutics, June 2011, Springer Science + Business Media

    Professor Lindsay DeVane

  13. Preclinical pharmacokinetic analysis of NOV-002, a glutathione disulfide mimetic

    Article • Biomedicine & Pharmacotherapy, September 2010, Elsevier

    Professor Lindsay DeVane

  14. P-glycoprotein inhibition potentiates the behavioural and neurochemical actions of risperidone in rats

    Article • The International Journal of Neuropsychopharmacology, October 2009, Oxford University Press (OUP)

    Professor Lindsay DeVane, Dr Alejandra Maria Pacchioni

  15. P.1.b.007 Developmental expression and activity of carboxylesterase 1 and carboxylesterase 2 in mouse and human

    Article • European Neuropsychopharmacology, September 2009, Elsevier

    Professor Lindsay DeVane

  16. Aripiprazole brain concentration is altered in P-glycoprotein deficient mice

    Article • Schizophrenia Research, May 2009, Elsevier

    Professor Lindsay DeVane

  17. Principles of Pharmacokinetics and Pharmacodynamics

    Article • April 2009, American Psychiatric Association

    Professor Lindsay DeVane

  18. Pro-inflammatory biomakers in depression: Treatment with venlafaxine

    Article • The World Journal of Biological Psychiatry, January 2009, Taylor & Francis

    Professor Lindsay DeVane

  19. Antipsychotic Drugs Inhibit the Function of Breast Cancer Resistance Protein

    Article • Basic & Clinical Pharmacology & Toxicology, October 2008, Wiley

    Professor Lindsay DeVane

  20. Two CES1 Gene Mutations Lead to Dysfunctional Carboxylesterase 1 Activity in Man: Clinical Significance and Molecular Basis

    Article • The American Journal of Human Genetics, June 2008, Elsevier

    Professor Lindsay DeVane

  21. Enantiospecific gas chromatographic–mass spectrometric analysis of urinary methylphenidate: Implications for phenotyping

    Article • Journal of Chromatography B, February 2008, Elsevier

    Professor Lindsay DeVane

  22. Pro-inflammatory biomakers in depression: Treatment with venlafaxine

    Article • The World Journal of Biological Psychiatry, January 2008, Taylor & Francis

    Professor Lindsay DeVane

  23. Sertraline and Its Metabolite Desmethylsertraline, but not Bupropion or Its Three Major Metabolites, Have High Affinity for P-Glycoprotein

    Article • Biological and Pharmaceutical Bulletin, January 2008, Pharmaceutical Society of Japan

    Professor Lindsay DeVane

  24. Interactions of attention-deficit/hyperactivity disorder therapeutic agents with the efflux transporter P-glycoprotein

    Article • European Journal of Pharmacology, January 2008, Elsevier

    Professor Lindsay DeVane

  25. A novel HPLC fluorescence method for the quantification of methylphenidate in human plasma

    Article • Journal of Chromatography B, October 2007, Elsevier

    Professor Lindsay DeVane

  26. Atypical Antipsychotic Administration During Late Pregnancy: Placental Passage and Obstetrical Outcomes

    Article • American Journal of Psychiatry, August 2007, American Psychiatric Association

    Professor Lindsay DeVane

  27. Double-blind donepezil–placebo crossover augmentation study of atypical antipsychotics in chronic, stable schizophrenia: A pilot study

    Article • Schizophrenia Research, July 2007, Elsevier

    Professor Lindsay DeVane

  28. Sensitive quantification of atomoxetine in human plasma by HPLC with fluorescence detection using 4-(4,5-diphenyl-1H-imidazole-2-yl) benzoyl chloride derivatization

    Article • Journal of Chromatography B, February 2007, Elsevier

    Professor Lindsay DeVane

  29. Open-label steady-state pharmacokinetic drug interaction study on co-administered quetiapine fumarate and divalproex sodium in patients with schizophrenia, schizoaffective disorder, or bipolar disorder

    Article • Human Psychopharmacology Clinical and Experimental, January 2007, Wiley

    Professor Lindsay DeVane

  30. The Emerging Importance of Transporter Proteins in the Psychopharmacological Treatment of the Pregnant Patient

    Article • Drug Metabolism Reviews, January 2007, Taylor & Francis

    Professor Lindsay DeVane

  31. A Comprehensive In Vitro Screening of d-, l- , and dl-threo -Methylphenidate: An Exploratory Study

    Article • Journal of Child and Adolescent Psychopharmacology, December 2006, Mary Ann Liebert Inc

    Professor Lindsay DeVane

  32. Risperidone and Paliperidone Inhibit P-Glycoprotein Activity In Vitro

    Article • Neuropsychopharmacology, August 2006, Springer Science + Business Media

    Professor Lindsay DeVane

  33. Counterpoint

    Article • Neuropsychopharmacology, July 2006, Springer Science + Business Media

    Professor Lindsay DeVane

  34. Antidepressant–Drug Interactions are Potentially but Rarely Clinically Significant

    Article • Neuropsychopharmacology, July 2006, Springer Science + Business Media

    Professor Lindsay DeVane

  35. Evaluation of antipsychotic drugs as inhibitors of multidrug resistance transporter P-glycoprotein

    Article • Psychopharmacology, June 2006, Springer Science + Business Media

    Professor Lindsay DeVane

  36. Placental Passage of Tricyclic Antidepressants

    Article • Biological Psychiatry, February 2006, Elsevier

    Professor Lindsay DeVane

  37. Pharmacokinetics of Olanzapine After Single-Dose Oral Administration of Standard Tablet Versus Normal and Sublingual Administration of an Orally Disintegrating Tablet in Normal Volunteers

    Article • The Journal of Clinical Pharmacology, February 2006, Wiley

    Professor Lindsay DeVane

  38. PIII-63The cannabinoid cannabidiol inhibits P-glycoprotein activity

    Article • Clinical Pharmacology & Therapeutics, February 2006, Springer Science + Business Media

    Professor Lindsay DeVane

  39. Modafinil and Cocaine Interactions

    Article • The American Journal of Drug and Alcohol Abuse, January 2006, Taylor & Francis

    Professor Lindsay DeVane

  40. Antidepressants in Amniotic Fluid: Another Route of Fetal Exposure

    Article • American Journal of Psychiatry, January 2006, American Psychiatric Association

    Professor Lindsay DeVane

  41. Population pharmacokinetic analysis of drug–drug interactions among risperidone, bupropion, and sertraline in CF1 mice

    Article • Psychopharmacology, November 2005, Springer Science + Business Media

    Professor Lindsay DeVane

  42. Donepezil effects on mood in patients with schizophrenia and schizoaffective disorder

    Article • The International Journal of Neuropsychopharmacology, October 2005, Oxford University Press (OUP)

    Professor Lindsay DeVane

  43. Effect ofGinkgo bilobaExtract on Plasma Steroid Concentrations in Healthy Volunteers: A Pilot Study

    Article • Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy, October 2005, Wiley

    Professor Lindsay DeVane

  44. P-glycoprotein does not actively transport nicotine and cotinine

    Article • Addiction Biology, June 2005, Taylor & Francis

    Professor Lindsay DeVane

  45. Modafinil Influences the Pharmacokinetics of Intravenous Cocaine in Healthy Cocaine-Dependent Volunteers

    Article • Clinical Pharmacokinetics, January 2005, Springer Science + Business Media

    Professor Lindsay DeVane

  46. Effects of St John's wort (Hypericum perforatum L.) extract on plasma androgen concentrations in healthy men and women: a pilot study

    Article • Phytotherapy Research, January 2005, Wiley

    Professor Lindsay DeVane

  47. The brain entry of risperidone and 9-hydroxyrisperidone is greatly limited by P-glycoprotein

    Article • The International Journal of Neuropsychopharmacology, December 2004, Oxford University Press (OUP)

    Professor Lindsay DeVane

  48. Effect of St. John’s Wort on Drug Metabolism by Induction of Cytochrome P450 3A4 Enzyme

    Article • Obstetrical & Gynecological Survey, May 2004, Wolters Kluwer Health

    Professor Lindsay DeVane

  49. Brain penetration of methadone (R)- and (S)-enantiomers is greatly increased by P-glycoprotein deficiency in the blood?brain barrier of Abcb1a gene knockout mice

    Article • Psychopharmacology, April 2004, Springer Science + Business Media

    Professor Lindsay DeVane

  50. Comparative CYP3A4 Inhibitory Effects of Venlafaxine, Fluoxetine, Sertraline, and Nefazodone in Healthy Volunteers

    Article • Journal of Clinical Psychopharmacology, February 2004, Wolters Kluwer Health

    Professor Lindsay DeVane

  51. Multiple-Dose Administration of Ginkgo biloba Did Not Affect Cytochrome P-450 2D6 or 3A4 Activity in Normal Volunteers

    Article • Journal of Clinical Psychopharmacology, December 2003, Wolters Kluwer Health

    Professor Lindsay DeVane

  52. Dietary levels of quinine in tonic water do not inhibit CYP2D6 in vivo

    Article • Food and Chemical Toxicology, August 2003, Elsevier

    Professor Lindsay DeVane

  53. Augmenting Atypical Antipsychotics with a Cognitive Enhancer (Donepezil) Improves Regional Brain Activity in Schizophrenia Patients: A Pilot Double-blind Placebo Controlled BOLD fMRI Study

    Article • Neurocase, June 2003, Taylor & Francis

    Professor Lindsay DeVane

  54. Chiral Analysis of d- and l-Modafinil in Human Serum: Application to Human Pharmacokinetic Studies

    Article • Therapeutic Drug Monitoring, April 2003, Wolters Kluwer Health

    Professor Lindsay DeVane

  55. Pharmacokinetics of Methylphenidate After Oral Administration of Two Modified-Release Formulations in Healthy Adults

    Article • Clinical Pharmacokinetics, January 2003, Springer Science + Business Media

    Professor Lindsay DeVane

  56. Differential Time Course of Cytochrome P450 2D6 Enzyme Inhibition by Fluoxetine, Sertraline, and Paroxetine in Healthy Volunteers

    Article • Journal of Clinical Psychopharmacology, April 2002, Wolters Kluwer Health

    Professor Lindsay DeVane

  57. Clinical Pharmacokinetics of Sertraline

    Article • Clinical Pharmacokinetics, January 2002, Springer Science + Business Media

    Professor Lindsay DeVane

  58. Hypotension and Bradycardia in a Healthy Volunteer following a Single 5 mg Dose of Olanzapine

    Article • The Journal of Clinical Pharmacology, January 2002, Wiley

    Professor Lindsay DeVane

  59. Clinical Applications of Modafinil in Stimulant Abusers: Low Abuse Potential

    Article • American Journal on Addictions, January 2002, Wiley

    Professor Lindsay DeVane

  60. Intranasal Sumatriptan in Post-ECT Headache: Results of an Open-Label Trial

    Article • Journal of Ect, December 2001, Wolters Kluwer Health

    Professor Lindsay DeVane

  61. Drug Glucuronidation in Clinical Psychopharmacology

    Article • Journal of Clinical Psychopharmacology, October 2001, Wolters Kluwer Health

    Professor Lindsay DeVane

  62. Substance P: A New Era, a New Role

    Article • Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy, September 2001, Wiley

    Professor Lindsay DeVane

  63. An Evaluation of Risperidone Drug Interactions

    Article • Journal of Clinical Psychopharmacology, August 2001, Wolters Kluwer Health

    Professor Lindsay DeVane

  64. Lack of Citalopram Effect on the Pharmacokinetics of Cyclosporine

    Article • Psychosomatics, July 2001, Elsevier

    Professor Lindsay DeVane

  65. A single dose of methadone inhibits cytochrome P-4503A activity in healthy volunteers as assessed by the urinary cortisol ratio

    Article • British Journal of Clinical Pharmacology, April 2001, Wiley

    Professor Lindsay DeVane

  66. Clinical Pharmacokinetics of Quetiapine

    Article • Clinical Pharmacokinetics, January 2001, Springer Science + Business Media

    Professor Lindsay DeVane

  67. A Double-blind Placebo-controlled Case Study of the Use of Donepezil to Improve Cognition in a Schizoaffective Disorder Patient: Functional MRI Correlates.

    Article • Neurocase, January 2001, Swets & Zeitlinger Publishers

    Professor Lindsay DeVane

  68. A Double-blind Placebo-controlled Case Study of the Use of Donepezil to Improve Cognition in a Schizoaffective Disorder Patient: Functional MRI Correlates.

    Article • Neurocase, January 2001, Swets & Zeitlinger Publishers

    Professor Lindsay DeVane

  69. Nefazodone in Diabetic Neuropathy: Response and Biology

    Article • Psychosomatic Medicine, July 2000, Wolters Kluwer Health

    Professor Lindsay DeVane

  70. Drs. DeVane and Pollock Reply

    Article • The Journal of Clinical Psychiatry, June 2000, Physicians Postgraduate Press, Inc

    Professor Lindsay DeVane

  71. Single-Dose Pharmacokinetics of Methylphenidate in CYP2D6 Extensive and Poor Metabolizers

    Article • Journal of Clinical Psychopharmacology, June 2000, Wolters Kluwer Health

    Professor Lindsay DeVane

  72. Sertraline in Diabetic Neuropathy: Response and Biology

    Article • Psychosomatic Medicine, May 2000, Wolters Kluwer Health

    Professor Lindsay DeVane

  73. Olanzapine Pharmacokinetics in Pediatric and Adolescent Inpatients With Childhood-Onset Schizophrenia

    Article • Journal of Clinical Psychopharmacology, April 2000, Wolters Kluwer Health

    Professor Lindsay DeVane

  74. Rifampin-Induced Selective Serotonin Reuptake Inhibitor Withdrawal Syndrome in a Patient Treated With Sertraline

    Article • Journal of Clinical Psychopharmacology, February 2000, Wolters Kluwer Health

    Professor Lindsay DeVane

  75. Development and application of a chiral high performance liquid chromatography assay for pharmacokinetic studies of methadone

    Article • Chirality, January 2000, Wiley

    Professor Lindsay DeVane

  76. Development and application of a chiral high performance liquid chromatography assay for pharmacokinetic studies of methadone

    Article • Chirality, January 2000, Wiley

    Professor Lindsay DeVane

  77. Fluoxetine-Related Death in a Child with Cytochrome P-450 2D6 Genetic Deficiency

    Article • Journal of Child and Adolescent Psychopharmacology, January 2000, Mary Ann Liebert Inc

    Professor Lindsay DeVane

  78. Evaluation of the efficacy, safety and physiological effects of fluvoxamine in social phobia

    Article • International Clinical Psychopharmacology, November 1999, Wolters Kluwer Health

    Professor Lindsay DeVane

  79. Effect of St. John's wort on cytochrome (CYP) P-450 activity in healthy volunteers

    Article • European Neuropsychopharmacology, September 1999, Elsevier

    Professor Lindsay DeVane

  80. Mirtazapine in Major Depression With Comorbid Generalized Anxiety Disorder

    Article • The Journal of Clinical Psychiatry, July 1999, Physicians Postgraduate Press, Inc

    Professor Lindsay DeVane

  81. Suspected Ciprofloxacin Inhibition of Olanzapine Resulting in Increased Plasma Concentration

    Article • Journal of Clinical Psychopharmacology, June 1999, Wolters Kluwer Health

    Professor Lindsay DeVane

  82. Pharmacokinetics of trazodone and its major metabolite m-chlorophenylpiperazine in plasma and brain of rats

    Article • The International Journal of Neuropsychopharmacology, March 1999, Oxford University Press (OUP)

    Professor Lindsay DeVane

  83. Drug interactions with psychostimulants

    Article • International Clinical Psychopharmacology, January 1999, Wolters Kluwer Health

    Professor Lindsay DeVane

  84. Pharmacokinetics and drug interactions of the newer antidepressants

    Article • January 1999, American Psychological Association (APA)

    Professor Lindsay DeVane

  85. No Mourning for the Conventional Antipsychotics: The Dawn of the Atypical Agents

    Article • Annals of Pharmacotherapy, January 1999, SAGE Publications

    Professor Lindsay DeVane

  86. Bupropion slow-release response in depression: diagnosis and biochemistry

    Article • Biological Psychiatry, October 1998, Elsevier

    Professor Lindsay DeVane

  87. Therapeutic Drug Monitoring of Alprazolam in Adolescents With Asthma

    Article • Therapeutic Drug Monitoring, June 1998, Wolters Kluwer Health

    Professor Lindsay DeVane

  88. Lack of urinary side-effects with nefazodone as compared to other newer antidepressants

    Article • Human Psychopharmacology Clinical and Experimental, June 1998, Wiley

    Professor Lindsay DeVane

  89. Lack of urinary side‐effects with nefazodone as compared to other newer antidepressants

    Article • Human Psychopharmacology Clinical and Experimental, June 1998, Wiley

    Professor Lindsay DeVane

  90. 331. Mirtazapine in combined major depression and generalized anxiety disorder

    Article • Biological Psychiatry, April 1998, Elsevier

    Professor Lindsay DeVane

  91. Lack of Antidepressant-Cyclosporine Pharmacokinetic Interactions

    Article • Journal of Clinical Psychopharmacology, February 1998, Wolters Kluwer Health

    Professor Lindsay DeVane

  92. Translational pharmacokinetics: Current issues with newer antidepressants

    Article • Depression and Anxiety, January 1998, Hindawi Publishing Corporation

    Professor Lindsay DeVane

  93. Translational pharmacokinetics: Current issues with newer antidepressants

    Article • Depression and Anxiety, January 1998, Hindawi Publishing Corporation

    Professor Lindsay DeVane

  94. Extrapyramidal Symptoms Associated With Cyclic Antidepressant Treatment

    Article • Journal of Clinical Psychopharmacology, October 1997, Wolters Kluwer Health

    Professor Lindsay DeVane

  95. Psychopharmacology and drug interactions in HIV positive patients

    Article • Biological Psychiatry, July 1997, Elsevier

    Professor Lindsay DeVane

  96. Clozapine Drug-Drug Interactions: A Review of the Literature

    Article • Human Psychopharmacology Clinical and Experimental, January 1997, Wiley

    Professor Lindsay DeVane

  97. Dr. Nemeroff and Colleagues Reply

    Article • American Journal of Psychiatry, December 1996, American Psychiatric Association

    Professor Lindsay DeVane

  98. The Practical Use of Carbon Dioxide-Induced Anxiety in the Diagnosis and Care of Patients with Panic Disorder

    Article • Annals of Clinical Psychiatry, December 1996, Portico

    Professor Lindsay DeVane

  99. Alopecia and Mood Stabilizer Therapy

    Article • Annals of Clinical Psychiatry, September 1996, Portico

    Professor Lindsay DeVane

  100. The evaluation of fluvoxamine in the treatment of social phobia

    Article • European Neuropsychopharmacology, September 1996, Elsevier

    Professor Lindsay DeVane

  101. Theoretical considerations of dose/concentration/effect relationships: Direct and indirect pharmacokinetic/dynamic models

    Article • European Neuropsychopharmacology, June 1996, Elsevier

    Professor Lindsay DeVane

  102. Pharmacokinetics of Clozapine and Risperidone

    Article • Journal of Clinical Psychopharmacology, April 1996, Wolters Kluwer Health

    Professor Lindsay DeVane

  103. The reply

    Article • The American Journal of Medicine, January 1996, Elsevier

    Professor Lindsay DeVane

  104. Comparative safety and tolerability of selective serotonin reuptake inhibitors

    Article • Human Psychopharmacology Clinical and Experimental, October 1995, Wiley

    Professor Lindsay DeVane

  105. Pharmacokinetics of Single- and Multiple-Dose Bupropion in Elderly Patients with Depression

    Article • The Journal of Clinical Pharmacology, September 1995, Wiley

    Professor Lindsay DeVane

  106. Pharmacokinetic and Pharmacodynamic Considerations for the Design and Screening of Potential Medications

    Article • January 1995, American Psychological Association (APA)

    Professor Lindsay DeVane

  107. Pharmacokinetics of the newer antidepressants: Clinical relevance

    Article • The American Journal of Medicine, December 1994, Elsevier

    Professor Lindsay DeVane

  108. Evaluation of population pharmacokinetics in therapeutic trials. IV. Application to postmarketing surveillance

    Article • Clinical Pharmacology & Therapeutics, May 1993, Springer Science + Business Media

    Professor Lindsay DeVane

  109. Treatment of Aggressive Children with Clonidine: Results of an Open Pilot Study

    Article • Journal of the American Academy of Child & Adolescent Psychiatry, May 1993, Elsevier

    Professor Lindsay DeVane

  110. The Assessment and Clinical Implications of Haloperidol Acute-Dose, Steady-State, and Withdrawal Pharmacokinetics

    Article • Journal of Clinical Psychopharmacology, April 1993, Wolters Kluwer Health

    Professor Lindsay DeVane

  111. Fundamentals of Monitoring Psychoactive Drug Therapy—by C. Lindsay DeVane, Pharm.D.; Baltimore, Williams & Wilkins, 1990, 288 pages, $31

    Article • Psychiatric Services, August 1992, American Psychiatric Association

    Professor Lindsay DeVane

  112. STEADY-STATE PREDICTIONS BASED ON FIRST DOSE DATA

    Article • Clinical Neuropharmacology, January 1992, Wolters Kluwer Health

    Professor Lindsay DeVane

  113. Pharmacokinetic and dynamic correlates of intravenous alprazolam challenge

    Article • Clinical Pharmacology & Therapeutics, December 1991, Springer Science + Business Media

    Professor Lindsay DeVane

  114. Influence of menstrual cycle and gender on alprazolam pharmacokinetics

    Article • Clinical Pharmacology & Therapeutics, October 1991, Springer Science + Business Media

    Professor Lindsay DeVane

  115. Effect of electroconvulsive therapy on serum concentration of alpha-1-acid glycoprotein

    Article • Biological Psychiatry, July 1991, Elsevier

    Professor Lindsay DeVane

  116. Sustained Plasma Concentrations of Fluoxetine and/or Norfluoxetine Four and Eight Weeks After Fluoxetine Discontinuation

    Article • Journal of Clinical Psychopharmacology, June 1991, Wolters Kluwer Health

    Professor Lindsay DeVane

  117. Distribution of Phenobarbital and Phenytoin in Pregnant Rats and Their Fetuses

    Article • Epilepsia, April 1991, Wiley

    Professor Lindsay DeVane

  118. Pharmacokinetic Correlates of Fetal Drug Exposure

    Article • January 1991, American Psychological Association (APA)

    Professor Lindsay DeVane

  119. Immunologic Effects of Cocaine and Related Alkaloids

    Article • Immunopharmacology and Immunotoxicology, January 1991, Taylor & Francis

    Professor Lindsay DeVane

  120. Inhalational administration of cocaine in sheep

    Article • Life Sciences, January 1991, Elsevier

    Professor Lindsay DeVane

  121. Disposition of Bupropion in Healthy Volunteers and

    Article • Journal of Clinical Psychopharmacology, October 1990, Wolters Kluwer Health

    Professor Lindsay DeVane

  122. Electroconvulsive Therapy Complicated by Insecticide Ingestion

    Article • Journal of Clinical Psychopharmacology, February 1990, Wolters Kluwer Health

    Professor Lindsay DeVane

  123. Tissue distribution of cocaine in the pregnant rat

    Article • Life Sciences, January 1989, Elsevier

    Professor Lindsay DeVane

  124. Hypotension and bradycardia induced by amitriptyline in healthy volunteers

    Article • Human Psychopharmacology Clinical and Experimental, March 1988, Wiley

    Professor Lindsay DeVane

  125. Naming the Cyclic Antidepressants

    Article • Journal of Clinical Psychopharmacology, August 1987, Wolters Kluwer Health

    Professor Lindsay DeVane

  126. Possible Teratogenic Effects of Imipramine in the Rat

    Article • January 1987, Springer Science + Business Media

    Professor Lindsay DeVane

  127. The effect of experimentally-induced renal failure on accumulation of bupropion and its major basic metabolites in plasma and brain of guinea pigs

    Article • Psychopharmacology, July 1986, Springer Science + Business Media

    Professor Lindsay DeVane

  128. Spread-sheet analysis in pharmacokinetic simulations

    Article • Trends in Pharmacological Sciences, January 1986, Elsevier

    Professor Lindsay DeVane

  129. Analytical Pitfalls with Tricyclic and Newer Antidepressants in Biological Samples

    Article • January 1986, Springer Science + Business Media

    Professor Lindsay DeVane

  130. Measurement of haloperidol and reduced haloperidol in human plasma using réversed-phase high-performance liquid chromatography

    Article • Journal of Chromatography B Biomedical Sciences and Applications, January 1986, Elsevier

    Professor Lindsay DeVane

  131. Stability of Bupropion and its Major Metabolites in Human Plasma

    Article • Therapeutic Drug Monitoring, December 1985, Wolters Kluwer Health

    Professor Lindsay DeVane

  132. Pharmacokinetics of bupropion and its major basic metabolites in normal subjects after a single dose

    Article • Clinical Pharmacology & Therapeutics, November 1985, Springer Science + Business Media

    Professor Lindsay DeVane

  133. Diurnal Variation of α1-Acid Glycoprotein Concentration in Normal Volunteers

    Article • Journal of Pharmaceutical Sciences, July 1985, Elsevier

    Professor Lindsay DeVane

  134. Posttraumatic stress disorder: Characteristics and pharmacological response in the veteran population

    Article • Comprehensive Psychiatry, May 1985, Elsevier

    Professor Lindsay DeVane

  135. Cimetidine interaction with amitriptyline

    Article • European Journal of Clinical Pharmacology, January 1985, Springer Science + Business Media

    Professor Lindsay DeVane

  136. Cerebral and blood pharmacokinetics of imipramine and its active metabolites in the pregnant rat

    Article • Psychopharmacology, October 1984, Springer Science + Business Media

    Professor Lindsay DeVane

  137. Quantification of imipramine and its major metabolites in whole blood, brain, and other tissues of the rat by liquid chromatography

    Article • Psychopharmacology, September 1984, Springer Science + Business Media

    Professor Lindsay DeVane

  138. Mechanism and Management of Important Psychotherapeutic Drug Interactions

    Article • Southern Medical Journal, April 1984, Southern Medical Association

    Professor Lindsay DeVane

  139. Differences in Diazepam and Oxazepam

    Article • Archives of General Psychiatry, March 1984, American Medical Association (AMA)

    Professor Lindsay DeVane

  140. The analysis and disposition of imipramine and its active metabolites in man

    Article • Psychopharmacology, March 1984, Springer Science + Business Media

    Professor Lindsay DeVane

  141. Pharmacokinetics (2nd edn, revised and expanded), M. Gibaldi and D. Perrier (Vol. 15 of Drugs and the pharmaceutical sciences), Marcel Dekker, New York, 1982

    Article • Biopharmaceutics & Drug Disposition, April 1983, Wiley

    Professor Lindsay DeVane

  142. Drug and metabolite concentrations combined in predicting steady-state concentrations from test doses

    Article • Biopharmaceutics & Drug Disposition, January 1983, Wiley

    Professor Lindsay DeVane

  143. Dosage regimen design

    Article • Pharmacology & Therapeutics, January 1982, Elsevier

    Professor Lindsay DeVane

  144. Hemoperfusion for Imipramine Overdose: Elimination of Active Metabolites

    Article • Journal of Toxicology Clinical Toxicology, January 1982, Taylor & Francis

    Professor Lindsay DeVane